Omeros Corp. Stock
Price
Target price
€2.85
€2.85
-0.490%
-0.014
-0.490%
-
23.04.24 / Frankfurt
WKN: A0NBFF / Symbol: OMER / Name: Omeros / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Omeros Corp. Stock
Omeros Corp. shows a slight decrease today, losing -€0.014 (-0.490%) compared to yesterday.
For the coming years our community has positive and negative things to say abot the Omeros Corp. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Non-cyclic/Cyclic" there were negative voices in the community.
Pros and Cons of Omeros Corp. in the next few years
Pros
?
M***** P*******
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Omeros Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Omeros Corp. | -0.490% | -10.000% | -8.151% | -44.642% | -8.679% | -81.245% | -82.946% |
| Ardelyx Inc. | 3.750% | -5.482% | -15.972% | 32.578% | 3.218% | -12.905% | - |
| Salarius Pharmaceuticals Inc. | 4.250% | -0.935% | -18.462% | -68.120% | -23.604% | -98.261% | -99.994% |
| Brainstorm Cell | 1.170% | -0.896% | -1.485% | -81.710% | 114.440% | -80.717% | - |
Comments
Omeros Co. (NASDAQ: OMER) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Show more
Ratings data for OMER provided by MarketBeat
Omeros Co. (NASDAQ: OMER) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Show more
Ratings data for OMER provided by MarketBeat
Omeros Co. (NASDAQ: OMER) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for OMER provided by MarketBeat